Related references
Note: Only part of the references are listed.Data monitoring committees and randomized clinical trials
Howard Trachtman et al.
KIDNEY INTERNATIONAL (2019)
Creation of an institutional semi-independent data monitoring committee
Lisa R. Tannock et al.
CLINICAL TRIALS (2019)
Phase I trials as valid therapeutic options for patients with cancer
Jacob J. Adashek et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
The changing landscape of data monitoring committees-Perspectives from regulators, members, and sponsors
Amit Bhattacharyya et al.
BIOMETRICAL JOURNAL (2019)
Understanding the functions and operations of data monitoring committees: Survey and focus group findings
Karim A. Calis et al.
CLINICAL TRIALS (2017)
Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseases
Gerasimos S. Filippatos et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Reporting of data monitoring boards in publications of randomized clinical trials is often deficient: ACTTION systematic review
Jennifer S. Gewandter et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2017)
Adaptive designs from a Data Safety Monitoring Board perspective: Some controversies and some case studies
Bruce W. Turnbull
CLINICAL TRIALS (2017)
Sharing some interim data in trial monitoring can mislead or unmask trial investigators: A scenario-based survey of trial experts
Victoria Borg Debono et al.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2017)
Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative
Karim A. Calis et al.
CLINICAL TRIALS (2017)
Evaluation of the Cardiovascular Risk of Naltrexone-Bupropion A Study Interrupted
Joshua M. Sharfstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Pursuit of truly independent data monitoring committees in research
Louise Marston et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Pursuit of truly independent data monitoring committees in research
Louise Marston et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Developing training for Data Safety Monitoring Board members: A National Institute of Allergy and Infectious Diseases case study
Judith Zuckerman et al.
CLINICAL TRIALS (2015)
Data monitoring committees for pragmatic clinical trials
Susan S. Ellenberg et al.
CLINICAL TRIALS (2015)
Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex
Frank Ruschitzka et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
Hans-Henrik Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Randomized trials stopped early for benefit -: A systematic review
VM Montori et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial
B Dahlöf et al.
LANCET (2005)
The data monitoring experience in the Candesartan in Heart Failure Assessment of Reduction in Mortality and morbidity (CHARM) program
S Pocock et al.
AMERICAN HEART JOURNAL (2005)
The cost of operating institutional review boards (IRBs)
TH Wagner et al.
ACADEMIC MEDICINE (2003)
Should all trials have a Data Safety and Monitoring Committee?
JA Cairns et al.
AMERICAN HEART JOURNAL (2001)
Share Paper
